15.98
1.20%
0.19
전일 마감가:
$15.79
열려 있는:
$15.88
하루 거래량:
1.81M
Relative Volume:
0.79
시가총액:
$4.15B
수익:
$6.41B
순이익/손실:
$1.30B
주가수익비율:
6.9782
EPS:
2.29
순현금흐름:
$646.00M
1주 성능:
+8.49%
1개월 성능:
-6.88%
6개월 성능:
-23.87%
1년 성능:
+39.81%
오가논 & Co Stock (OGN) Company Profile
명칭
Organon Co
전화
551-430-6000
주소
30 HUDSON STREET, JERSEY CITY
OGN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
OGN
Organon Co
|
15.98 | 4.15B | 6.41B | 1.30B | 646.00M | 2.29 |
LLY
Lilly Eli Co
|
788.19 | 752.65B | 40.86B | 8.37B | -2.28B | 5.4193 |
NVO
Novo Nordisk Adr
|
106.13 | 471.56B | 39.36B | 13.79B | 9.83B | 2.4077 |
JNJ
Johnson Johnson
|
155.40 | 353.35B | 87.70B | 14.68B | 19.03B | 13.47 |
ABBV
Abbvie Inc
|
183.08 | 323.72B | 55.53B | 5.12B | 15.62B | 3.65 |
MRK
Merck Co Inc
|
103.12 | 260.72B | 63.17B | 12.15B | 14.84B | 1.80 |
오가논 & Co Stock (OGN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-09-06 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2023-11-03 | 다운그레이드 | Goldman | Buy → Neutral |
2023-09-21 | 개시 | Barclays | Overweight |
2023-03-16 | 개시 | Raymond James | Outperform |
2022-10-14 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2022-09-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2022-08-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
2022-04-27 | 개시 | Goldman | Buy |
2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
2021-10-07 | 개시 | Piper Sandler | Neutral |
2021-09-01 | 개시 | BofA Securities | Buy |
2021-07-22 | 개시 | Citigroup | Buy |
2021-06-15 | 개시 | JP Morgan | Neutral |
2021-06-11 | 개시 | Morgan Stanley | Equal-Weight |
2021-06-10 | 개시 | Evercore ISI | Outperform |
모두보기
오가논 & Co 주식(OGN)의 최신 뉴스
Algert Global LLC Has $2.20 Million Position in Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Organon & Co. (OGN): An Oversold Healthcare Stock to Invest In Now - Insider Monkey
Cerity Partners LLC Has $12.77 Million Stock Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
(OGN) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Organon & Co. (NYSE:OGN) Stock Position Lifted by Victory Capital Management Inc. - MarketBeat
Massachusetts Financial Services Co. MA Sells 332,614 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune
Thompson Siegel & Walmsley LLC Raises Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Foundry Partners LLC Takes $7.64 Million Position in Organon & Co. (NYSE:OGN) - MarketBeat
Reach For A Dream and Organon Collaborate to Launch Dream Room at Rahima Moosa Mother and Child Hospital - Media Update
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Organon partners with Egyptian Drug Authority to advance women’s health and family planning in Egypt - ZAWYA
Beddow Capital Management Inc. Raises Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Organon: 7% Yield, 4x P/E, Big Upside Potential (NYSE:OGN) - Seeking Alpha
(OGN) Proactive Strategies - Stock Traders Daily
Organon & Co. (NYSE:OGN) Shares Sold by Principal Financial Group Inc. - MarketBeat
Organon & Co. (NYSE:OGN) Stock Holdings Decreased by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade) - Seeking Alpha
Organon & Co (OGN) Stock Price Down 3.48% on Nov 12 - GuruFocus.com
Amalgamated Bank Sells 34,385 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Los Angeles Capital Management LLC Boosts Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Acorn Financial Advisory Services Inc. ADV Takes $743,000 Position in Organon & Co. (NYSE:OGN) - MarketBeat
Van ECK Associates Corp Increases Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Philip James Wealth Mangement LLC Invests $15.39 Million in Organon & Co. (NYSE:OGN) - MarketBeat
Ex-Dividend Reminder: American Water Works, Essential Utilities Inc and Organon - Nasdaq
Organon's (NYSE:OGN) Earnings Are Weaker Than They Seem - Yahoo Finance
Income Investors Should Know That Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon - Simply Wall St
Organon & Co (OGN) Stock Price Up 2.82% on Nov 7 - GuruFocus.com
FDA extends Organon's VTAMA cream review to March 2025 By Investing.com - Investing.com Canada
Organon & Co. (NYSE:OGN) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Earnings Update: Organon & Co. (NYSE:OGN) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance
Relative Strength Alert For Organon - Nasdaq
Organon updates outlook as FDA delays VTAMA label expansion - MSN
Organon reports FDA extension of target action date of review of Vtama sNDA - TipRanks
Organon’s VTAMA Cream FDA Review Extended to 2025 - TipRanks
Organon stock on watch as FDA delays VTAMA label (OGN:NYSE) - Seeking Alpha
FDA extends Organon's VTAMA cream review to March 2025 - Investing.com
(tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older - Business Wire
Organon's SWOT analysis: stock outlook amid VTAMA potential and biosimilar growth - Investing.com
Organon & Co (OGN) Stock Price Down 6.38% on Nov 4 - GuruFocus.com
Organon & Co. (NYSE:OGN) Trading Down 4.4%Should You Sell? - MarketBeat
The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - Simply Wall St
Organon China’s License and Supply Agreement with Shanghai Bao Pharmaceuticals - Global Legal Chronicle
(OGN) Technical Pivots with Risk Controls - Stock Traders Daily
Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28 - Yahoo Finance
Organon (OGN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN
Private Management Group Inc. Has $36.23 Million Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
FDA accepts Organon BLA for Prolia/Xgeva biosimilar - MSN
Organon Third Quarter 2024 Earnings: EPS: US$1.39 (vs US$0.23 in 3Q 2023) - Yahoo Finance
Organon & Co. (NYSE:OGN) to Issue $0.28 Quarterly Dividend - MarketBeat
오가논 & Co (OGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):